nodes	percent_of_prediction	percent_of_DWPC	metapath
Betazole—HRH2—gastric juice—pancreatic cancer	0.502	0.943	CbGeAlD
Betazole—HRH2—Secretion of Hydrochloric Acid in Parietal Cells—CCKBR—pancreatic cancer	0.113	0.242	CbGpPWpGaD
Betazole—HRH2—Secretion of Hydrochloric Acid in Parietal Cells—GAST—pancreatic cancer	0.0974	0.208	CbGpPWpGaD
Betazole—HRH2—digestive system—pancreatic cancer	0.0306	0.0575	CbGeAlD
Betazole—HRH2—G alpha (s) signalling events—SCT—pancreatic cancer	0.00708	0.0151	CbGpPWpGaD
Betazole—HRH2—G alpha (s) signalling events—GLP1R—pancreatic cancer	0.00658	0.0141	CbGpPWpGaD
Betazole—HRH2—GPCRs, Class A Rhodopsin-like—PRLHR—pancreatic cancer	0.00637	0.0136	CbGpPWpGaD
Betazole—HRH2—G alpha (s) signalling events—IAPP—pancreatic cancer	0.00583	0.0125	CbGpPWpGaD
Betazole—HRH2—G alpha (s) signalling events—PTHLH—pancreatic cancer	0.00559	0.012	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—PRLHR—pancreatic cancer	0.00546	0.0117	CbGpPWpGaD
Betazole—HRH2—GPCRs, Class A Rhodopsin-like—SSTR3—pancreatic cancer	0.00542	0.0116	CbGpPWpGaD
Betazole—HRH2—GPCRs, Class A Rhodopsin-like—SSTR1—pancreatic cancer	0.0052	0.0111	CbGpPWpGaD
Betazole—HRH2—GPCRs, Class A Rhodopsin-like—SSTR2—pancreatic cancer	0.005	0.0107	CbGpPWpGaD
Betazole—HRH2—GPCRs, Class A Rhodopsin-like—CCKBR—pancreatic cancer	0.00483	0.0103	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—SSTR3—pancreatic cancer	0.00464	0.00994	CbGpPWpGaD
Betazole—HRH2—G alpha (s) signalling events—GCG—pancreatic cancer	0.00456	0.00976	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—SSTR1—pancreatic cancer	0.00445	0.00953	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—PPY—pancreatic cancer	0.00437	0.00934	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—SSTR2—pancreatic cancer	0.00428	0.00917	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—PRLHR—pancreatic cancer	0.00416	0.0089	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—CCKBR—pancreatic cancer	0.00414	0.00886	CbGpPWpGaD
Betazole—HRH2—GPCRs, Class A Rhodopsin-like—CNR2—pancreatic cancer	0.00366	0.00784	CbGpPWpGaD
Betazole—HRH2—GPCRs, Class A Rhodopsin-like—CCKAR—pancreatic cancer	0.0036	0.00771	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—SSTR3—pancreatic cancer	0.00354	0.00757	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—SSTR1—pancreatic cancer	0.00339	0.00726	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—PPY—pancreatic cancer	0.00332	0.00712	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—SSTR2—pancreatic cancer	0.00326	0.00698	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—CCK—pancreatic cancer	0.00322	0.00689	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—CCKBR—pancreatic cancer	0.00315	0.00675	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—CNR2—pancreatic cancer	0.00314	0.00671	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—CCKAR—pancreatic cancer	0.00309	0.0066	CbGpPWpGaD
Betazole—HRH2—GPCRs, Class A Rhodopsin-like—CNR1—pancreatic cancer	0.00263	0.00562	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—SCT—pancreatic cancer	0.00257	0.0055	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—CCK—pancreatic cancer	0.00245	0.00525	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—SST—pancreatic cancer	0.00244	0.00522	CbGpPWpGaD
Betazole—HRH2—GPCRs, Class A Rhodopsin-like—AGTR1—pancreatic cancer	0.00242	0.00518	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—CNR2—pancreatic cancer	0.00239	0.00511	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—GLP1R—pancreatic cancer	0.00239	0.00511	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—CCKAR—pancreatic cancer	0.00235	0.00503	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—CNR1—pancreatic cancer	0.00225	0.00482	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—SHH—pancreatic cancer	0.00214	0.00459	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—PRLHR—pancreatic cancer	0.00213	0.00457	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—IAPP—pancreatic cancer	0.00212	0.00453	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—AGTR1—pancreatic cancer	0.00207	0.00444	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—PTHLH—pancreatic cancer	0.00203	0.00435	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—PTCH1—pancreatic cancer	0.00203	0.00435	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—SSTR3—pancreatic cancer	0.002	0.00428	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—GDI1—pancreatic cancer	0.00196	0.00419	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—GDI2—pancreatic cancer	0.00196	0.00419	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—SSTR1—pancreatic cancer	0.00192	0.0041	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—PPY—pancreatic cancer	0.00188	0.00402	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—SST—pancreatic cancer	0.00186	0.00398	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—SSTR2—pancreatic cancer	0.00184	0.00395	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—SSTR3—pancreatic cancer	0.00181	0.00388	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—CCKBR—pancreatic cancer	0.00178	0.00381	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—SSTR1—pancreatic cancer	0.00174	0.00372	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—CNR1—pancreatic cancer	0.00171	0.00367	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—PPY—pancreatic cancer	0.00171	0.00365	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—SSTR2—pancreatic cancer	0.00167	0.00358	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—GCG—pancreatic cancer	0.00166	0.00354	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—CCKBR—pancreatic cancer	0.00162	0.00346	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—AGTR1—pancreatic cancer	0.00158	0.00338	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—GAST—pancreatic cancer	0.00153	0.00328	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—SCT—pancreatic cancer	0.00145	0.00311	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—GAST—pancreatic cancer	0.00139	0.00298	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—CCK—pancreatic cancer	0.00138	0.00296	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—CNR2—pancreatic cancer	0.00135	0.00289	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—GLP1R—pancreatic cancer	0.00135	0.00289	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—CCKAR—pancreatic cancer	0.00133	0.00284	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—SCT—pancreatic cancer	0.00132	0.00282	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—PRLHR—pancreatic cancer	0.00126	0.0027	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—CCK—pancreatic cancer	0.00126	0.00269	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—CNR2—pancreatic cancer	0.00123	0.00262	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—GLP1R—pancreatic cancer	0.00123	0.00262	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—CCKAR—pancreatic cancer	0.00121	0.00258	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—IAPP—pancreatic cancer	0.0012	0.00256	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—ZNRF3—pancreatic cancer	0.00119	0.00254	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—ACVR1B—pancreatic cancer	0.00119	0.00254	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—PTHLH—pancreatic cancer	0.00115	0.00246	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—SHH—pancreatic cancer	0.0011	0.00235	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—IAPP—pancreatic cancer	0.00109	0.00232	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—DTX1—pancreatic cancer	0.00107	0.00229	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—SSTR3—pancreatic cancer	0.00107	0.00229	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—SST—pancreatic cancer	0.00105	0.00225	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—PTHLH—pancreatic cancer	0.00104	0.00223	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—PTCH1—pancreatic cancer	0.00104	0.00223	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—SSTR1—pancreatic cancer	0.00103	0.0022	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—PPY—pancreatic cancer	0.00101	0.00216	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—SSTR2—pancreatic cancer	0.000989	0.00212	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—CNR1—pancreatic cancer	0.000969	0.00207	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—CCKBR—pancreatic cancer	0.000955	0.00204	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—SST—pancreatic cancer	0.000953	0.00204	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.00095	0.00203	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—GCG—pancreatic cancer	0.000935	0.002	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—GLI1—pancreatic cancer	0.000898	0.00192	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—DTX4—pancreatic cancer	0.000898	0.00192	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000892	0.00191	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—CNR1—pancreatic cancer	0.00088	0.00188	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—NRP1—pancreatic cancer	0.000874	0.00187	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000874	0.00187	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—GCG—pancreatic cancer	0.000849	0.00182	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—HEY2—pancreatic cancer	0.000841	0.0018	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—GAST—pancreatic cancer	0.000821	0.00176	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—AGTR1—pancreatic cancer	0.00081	0.00173	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—SCT—pancreatic cancer	0.000779	0.00167	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—HEY1—pancreatic cancer	0.000779	0.00167	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—CCK—pancreatic cancer	0.000743	0.00159	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—CNR2—pancreatic cancer	0.000724	0.00155	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—GLP1R—pancreatic cancer	0.000724	0.00155	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—CXCL8—pancreatic cancer	0.000724	0.00155	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—CCKAR—pancreatic cancer	0.000712	0.00152	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—JAG2—pancreatic cancer	0.000691	0.00148	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—MEN1—pancreatic cancer	0.000681	0.00146	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—SHH—pancreatic cancer	0.000649	0.00139	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—NOTCH4—pancreatic cancer	0.000645	0.00138	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—IAPP—pancreatic cancer	0.000641	0.00137	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—PTHLH—pancreatic cancer	0.000616	0.00132	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—PTCH1—pancreatic cancer	0.000616	0.00132	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—SST—pancreatic cancer	0.000563	0.00121	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000555	0.00119	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—JAG1—pancreatic cancer	0.000551	0.00118	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—NOTCH3—pancreatic cancer	0.000549	0.00117	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—CNR1—pancreatic cancer	0.00052	0.00111	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000504	0.00108	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—GCG—pancreatic cancer	0.000502	0.00107	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000488	0.00104	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—AGTR1—pancreatic cancer	0.000479	0.00102	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—STK11—pancreatic cancer	0.000472	0.00101	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000443	0.000949	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000425	0.000911	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—SMAD4—pancreatic cancer	0.000413	0.000885	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000409	0.000875	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—HES1—pancreatic cancer	0.000403	0.000864	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000386	0.000827	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—CXCL8—pancreatic cancer	0.000371	0.000795	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—TERT—pancreatic cancer	0.000354	0.000757	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—HIF1A—pancreatic cancer	0.000338	0.000724	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—TSC2—pancreatic cancer	0.000337	0.000722	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—APOE—pancreatic cancer	0.00033	0.000707	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—KDR—pancreatic cancer	0.000323	0.000692	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—NFKBIA—pancreatic cancer	0.000308	0.000658	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—NOTCH1—pancreatic cancer	0.000305	0.000652	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—PIK3CG—pancreatic cancer	0.000298	0.000638	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—NRAS—pancreatic cancer	0.000298	0.000638	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—EGF—pancreatic cancer	0.000294	0.00063	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—EGFR—pancreatic cancer	0.000271	0.000581	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—PIK3CD—pancreatic cancer	0.000262	0.000561	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000259	0.000555	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—KRAS—pancreatic cancer	0.000256	0.000549	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000236	0.000504	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—PIK3CB—pancreatic cancer	0.000228	0.000489	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—CXCL8—pancreatic cancer	0.000219	0.00047	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—HRAS—pancreatic cancer	0.000218	0.000467	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—AKT1—pancreatic cancer	0.000212	0.000454	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—CASP3—pancreatic cancer	0.00021	0.000449	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—CCND1—pancreatic cancer	0.000204	0.000437	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—CTNNB1—pancreatic cancer	0.000202	0.000433	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—MMP9—pancreatic cancer	0.000198	0.000425	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—PTEN—pancreatic cancer	0.000197	0.000422	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—AKT1—pancreatic cancer	0.000192	0.000412	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—SRC—pancreatic cancer	0.000183	0.000392	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—VEGFA—pancreatic cancer	0.000178	0.000381	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—STAT3—pancreatic cancer	0.000176	0.000378	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—NRAS—pancreatic cancer	0.000176	0.000377	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—MYC—pancreatic cancer	0.000164	0.000351	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—TGFB1—pancreatic cancer	0.000164	0.00035	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—EGFR—pancreatic cancer	0.00016	0.000343	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—KRAS—pancreatic cancer	0.000151	0.000324	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—PIK3CA—pancreatic cancer	0.000139	0.000298	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—TP53—pancreatic cancer	0.000135	0.000288	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—HRAS—pancreatic cancer	0.000129	0.000276	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—AKT1—pancreatic cancer	0.000114	0.000243	CbGpPWpGaD
